Differences in dosing schedules between angiogenesis inhibitors and chemotherapeutics and the fact that anti-angiogenics reduce the vasculature that delivers chemo to tumors can make optimizing the combination difficult. Tempo Pharmaceuticals Inc. believes its Nanocell drug...